Guardian Partners »

Eupraxia Pharmaceuticals shares owned by Guardian Partners

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Guardian Partners from 13F filings

Historical chart of Guardian Partners investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Guardian Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Guardian Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $147k 24k 6.11

More positions owned by Guardian Partners

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf (KBWB)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Bk Nova Cad (BNS)
Microsoft Corporation (MSFT)
Ishares Msci Gbl Gold Mn (RING)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Canadian Natl Ry (CNI)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Nutrien (NTR)

View all positions for Guardian Partners

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Balyasny Asset Management
Vivo Capital
Scotia Capital
Dr. Jeffrey R. Jay, M.D.
Ally Bridge Group
Logos Global Management
Royal Bank of Canada
Velan Capital Investment Management
Affinity Asset Advisors
Alyeska Investment Group
UBS Group
Ingalls & Snyder
Goldman Sachs Group
Bank Of Montreal

View all funds holding Eupraxia Pharmaceuticals